Hepatitis Clinical Trials

Showing 1161-1180 of 1,819 trials

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

NCT00106964

Hepatitis B is a contagious virus that can damage a person's liver. It can be prevented by vaccination, but for many HIV-positive people, the vaccines do not help them achieve adequate protection against this virus. In an attempt to improve response to vaccination and achieve protection from hepatitis B, this trial will compare the immune system response to 3 hepatitis B vaccine regimens in HIV-positive adolescents 12 through 24 years of age.

HIV InfectionHepatitis B

University of North Carolina, Chapel Hill371 participantsStarted Jan 2004

Los Angeles, California, United States • San Francisco, California, United States • Washington D.C., District of Columbia, United States +8 more locations

UNKNOWN

Empowering Immigrants in the Greater Boston Area to Connect to HBV Care

NCT02342821

This Study will attempt to provide information / linkage to HBV care for persons at risk in the Greater Boston area.

Hepatitis

Massachusetts General Hospital100 participantsStarted Feb 2015

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

Empowering Immigrants in the Greater Boston Area to Connect to HBV Care

Related Searches

Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine

The Prevalence and Severity of HCV Infection in Thalassemia Major and Thalassemia Intermedia in Siriraj Hospital

Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection

A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)

A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)

Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα

Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025

Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)

A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.

Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial

Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers

Armodafinil for Patients Starting Hepatitis C Virus Treatment

Phase III Daclatasvir, Sofosbuvir, and Ribavirin in Cirrhotic Participants and Participants Post-liver Transplant